Vaxcyte Closes $1.1B Dual Equity and Convertible Notes Deal
Vaxcyte closed $1.1B in net proceeds through concurrent stock and 1.50% convertible senior notes offerings to finance Phase 3 VAX-31 vaccine development.
Stock market news and analysis, with explanations of company developments, earnings and the forces moving share prices. Start with Market Education if you are new to investing. Find your way around ECMSource.
Vaxcyte closed $1.1B in net proceeds through concurrent stock and 1.50% convertible senior notes offerings to finance Phase 3 VAX-31 vaccine development.
Gran Tierra Energy stockholders approved the $1.33B sale of Colombian and Ecuadorian businesses to Maurel & Prom, positioning the company to become debt-free.
Delta Air Lines posted record Q3 revenue of $20.2B but lowered full-year 2026 adjusted EPS guidance to $5.10–$5.60 as fuel expenses jump $6B.
American Express agreed to a $350M penalty and Fed consent orders over AML compliance while leaving full-year 2026 and 2027 guidance unchanged.
PepsiCo posted Q3 2026 net revenue of $25.27B, up 5.6%, and core EPS of $2.34, while updating full-year core constant currency EPS guidance to 1% to 2%.
Applied Digital posted Q1 FY27 revenue of $341.9 million, up 322% YoY, backed by $36 billion in contracted backlog and 250 MW live at Polaris Forge 1.
HubSpot filed Form 8-K announcing 660 role cuts (~7% of staff) and $65M–$75M in restructuring charges while reaffirming its 2026 financial guidance.
Constellation Energy shares surged 12% after Alphabet signed a $4.3 billion deal to add 890 MW of nuclear uprates across six plants on the PJM grid.
Marvell shares rallied after raising its fiscal 2028 revenue outlook to $20B at Investor Day, driven by surging hyperscaler custom AI chip demand.
PTC rallied after Schneider Electric agreed to acquire the industrial software company for $205 per share in cash, valuing its equity at $22.6 billion.